| Literature DB >> 29309806 |
Alexandre Cez1, Isabelle Brocheriou2, François-Xavier Lescure3, Clovis Adam4, Pierre-Marie Girard5, Gilles Pialoux6, Søren K Moestrup7, Soraya Fellahi8, Jean-Philippe Bastard8, Pierre Ronco1, Emmanuelle Plaisier9.
Abstract
Tenofovir disoproxil fumarate (TDF) is a commonly used antiretroviral drug for HIV, rarely causing Fanconi syndrome and acute kidney injury. We retrospectively analyzed the clinico pathological presentation of 20 cases of tenofovir-induced tubulopathy, and investigated the renal expression of the megalin and cubilin proteins, as well as the mitochondrial respiratory chain activity. Estimated glomerular filtration rate (eGFR) before TDF exposure was 92 ml/min/1.73m2, decreasing to 27.5 ml/min/1.73m2 at the time of biopsy, with 30% of patients requiring renal replacement therapy. Proximal tubular expression of megalin and cubilin was altered in 19 and 18 cases, respectively, whereas it was preserved in patients exposed to TDF without proximal tubular dysfunction and in HIV-negative patients with acute tubular necrosis. Loss of megalin/cubilin was correlated with low eGFR and high urine retinol binding protein at the time of biopsy, low eGFR at last follow-up, and was more severe in patients with multifactorial toxicity. Patients with additional nephrotoxic conditions promoting tenofovir accumulation showed a lower eGFR at presentation and at last follow-up, and more severe lesions of acute tubular necrosis, than those with isolated tenofovir toxicity. Altered mitochondrial COX activity in proximal tubules was observed and may be an early cellular alteration in tenofovir nephrotoxicity. In conclusion, altered megalin/cubilin expression represents a distinctive feature in tenofovir-induced tubulopathy, and its severity is correlated with urine retinol binding protein loss and is associated with a poor renal prognosis. Concomitant exposure to other nephrotoxic conditions severely impacts the renal presentation and outcome.Entities:
Keywords: Cubilin; Fanconi syndrome; Megalin; Nephrotoxicity; Tenofovir; Tubulopathy
Mesh:
Substances:
Year: 2018 PMID: 29309806 DOI: 10.1016/j.humpath.2017.12.018
Source DB: PubMed Journal: Hum Pathol ISSN: 0046-8177 Impact factor: 3.466